Pharmaids Pharmaceuticals Limited (BOM:524572)
30.49
-0.10 (-0.33%)
At close: Jul 27, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.06 billion as of July 28, 2026. Its market cap has decreased by -54.58% in one year.
Market Cap
1.06B
Enterprise Value
1.29B
Revenue
278.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.49
ChartMarket Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.06B, an increase of 8,535.86%. That is a compound annual growth rate of 19.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.06B | -37.01% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parnax Lab | 1.61B |
| Bilcare | 1.40B |
| Bal Pharma | 1.39B |
| Lactose (India) | 1.25B |
| Aayush Wellness | 1.14B |
| Mercury Laboratories | 1.00B |
| Denis Chem Lab | 968.45M |
| Concord Drugs | 922.25M |